Stoke Therapeutics, Inc. (STOK)
25.04
-0.66
(-2.57%)
USD |
NASDAQ |
Oct 23, 16:00
25.03
-0.01
(-0.04%)
After-Hours: 20:00
Stoke Therapeutics Price to Book Value : 4.522 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 4.522 |
| October 22, 2026 | 4.641 |
| October 21, 2026 | 4.638 |
| October 20, 2026 | 4.806 |
| October 19, 2026 | 4.482 |
| October 16, 2026 | 4.365 |
| October 15, 2026 | 4.444 |
| October 14, 2026 | 4.200 |
| October 13, 2026 | 4.063 |
| October 12, 2026 | 4.361 |
| October 09, 2026 | 4.468 |
| October 08, 2026 | 4.325 |
| October 07, 2026 | 4.387 |
| October 06, 2026 | 4.401 |
| October 05, 2026 | 4.573 |
| October 02, 2026 | 4.627 |
| October 01, 2026 | 4.697 |
| September 30, 2026 | 4.695 |
| September 29, 2026 | 4.674 |
| September 28, 2026 | 4.605 |
| September 25, 2026 | 4.479 |
| September 24, 2026 | 4.567 |
| September 23, 2026 | 4.715 |
| September 22, 2026 | 5.273 |
| September 21, 2026 | 5.066 |
| Date | Value |
|---|---|
| September 18, 2026 | 5.134 |
| September 17, 2026 | 5.224 |
| September 16, 2026 | 5.040 |
| September 15, 2026 | 5.084 |
| September 14, 2026 | 5.346 |
| September 11, 2026 | 5.243 |
| September 10, 2026 | 5.298 |
| September 09, 2026 | 5.403 |
| September 08, 2026 | 5.427 |
| September 04, 2026 | 5.383 |
| September 03, 2026 | 5.416 |
| September 02, 2026 | 5.508 |
| September 01, 2026 | 5.578 |
| August 31, 2026 | 5.634 |
| August 28, 2026 | 5.710 |
| August 27, 2026 | 5.886 |
| August 26, 2026 | 5.976 |
| August 25, 2026 | 6.043 |
| August 24, 2026 | 5.837 |
| August 21, 2026 | 5.831 |
| August 20, 2026 | 5.671 |
| August 19, 2026 | 5.965 |
| August 18, 2026 | 5.804 |
| August 17, 2026 | 5.802 |
| August 14, 2026 | 5.647 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.32 |
| Anika Therapeutics, Inc. | 2.088 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.376 |
Price to Book Value Related Metrics
| PS Ratio | 55.84 |
| Price | 25.04 |
| Earnings Yield | -13.47% |
| Market Cap | 1.563B |